Literature DB >> 29801027

Association of Obstructive Sleep Apnea With Calvarial and Skull Base Thinning.

Cyrus Rabbani1, Mohamad Z Saltagi2, Michael J Ye2, Janaki M Patel2, Shalini Manchanda1,3, Rick F Nelson1,4.   

Abstract

Importance: Spontaneous cerebrospinal fluid leaks (sCSF-L) of the temporal bone are associated with obesity, calvarial thinning, and obstructive sleep apnea (OSA), and the incidence has doubled in the past decade. It is currently unknown if OSA is independently associated with skull thinning. Objective: To determine if patients with OSA have thinner skulls than patients without OSA. Design, Setting, and Participants: A retrospective cohort study of patients who underwent a level 1 polysomnogram (PSG) and also had high-resolution computed tomographic (CT) imaging of the head from January 2010 to March 2017 at Indiana University was carried out. Patients with moderate to severe OSA (apnea-hypopnea index [AHI]≥25/h) and without OSA (AHI<5/h) were matched for age and body mass index (BMI, calculated as weight in kilograms divided by height in meters squared). Interventions: Measurement of calvarial thickness, extracranial zygoma thickness, skull base height and tegmen dehiscence (>4 mm) when blinded to OSA status. Main Outcomes and Measures: Primary outcomes were calvarial, skull base, and zygoma thickness differences between patients with OSA vs those without OSA.
Results: A total of 22 933 patients had a PSG and 1012 also had head CT imaging. Of the 1012 patients with both PSG and CT, the mean (SD) age was 50.8 (16.2) years and 624 (61.7%) were women. Those patients with moderate to severe OSA (56) and without OSA (58) were matched for mean (SD) age (50.3 [6.5] vs 49.8 [6.1] years]) and BMI (37.4 [8.1] vs 38.6 [6.8]). Patients with OSA had thinner mean (SD) calvaria (2.73 [0.67] vs 2.47 [0.52] mm; difference, -0.26 mm; 95% CI, -0.49 to -0.04; Cohen d, 0.44) and thinner skull bases (5.03 [1.40] vs 4.32 [1.28] mm; difference, -0.71; 95% CI, -1.23 to -0.19; Cohen d, 0.53). The mean (SD) extracranial zygoma thickness was the same (4.92 [0.87] vs 4.84 [0.84] mm; difference, -0.07 mm; 95% CI, -0.39 to 0.24). The tegmen mastoideum was dehiscent in nearly twice as many patients with OSA as those without (37% vs 20%; difference, 17%; 95% CI, 0.4-32). Conclusions and Relevance: Obstructive sleep apnea was independently associated with intracranial bone (calvaria and skull base) thinning and not with extracranial (zygoma) thinning. These findings support a possible role of OSA in the pathophysiologic development of sCSF-L.

Entities:  

Mesh:

Year:  2018        PMID: 29801027      PMCID: PMC6145742          DOI: 10.1001/jamaoto.2018.0347

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  22 in total

1.  Elevated intracranial pressure in patients with spontaneous cerebrospinal fluid otorrhea.

Authors:  Kyle P Allen; Carlos L Perez; J Walter Kutz; Deniz Gerecci; Peter S Roland; Brandon Isaacson
Journal:  Laryngoscope       Date:  2013-06-26       Impact factor: 3.325

2.  Marked episodic elevation of cerebrospinal fluid pressure during nocturnal sleep in patients with sleep apnea hypersomnia syndrome.

Authors:  Y Sugita; S Iijima; Y Teshima; T Shimizu; N Nishimura; T Tsutsumi; H Hayashi; H Kaneda; Y Hishikawa
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1985-03

3.  Calvarium thinning in patients with spontaneous cerebrospinal fluid leak.

Authors:  Rick F Nelson; Kameron R Hansen; Bruce J Gantz; Marlan R Hansen
Journal:  Otol Neurotol       Date:  2015-03       Impact factor: 2.311

4.  Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline.

Authors:  Vishesh K Kapur; Dennis H Auckley; Susmita Chowdhuri; David C Kuhlmann; Reena Mehra; Kannan Ramar; Christopher G Harrod
Journal:  J Clin Sleep Med       Date:  2017-03-15       Impact factor: 4.062

5.  Body mass index has a linear relationship with cerebrospinal fluid pressure.

Authors:  John P Berdahl; David Fleischman; Jana Zaydlarova; Sandra Stinnett; R Rand Allingham; Michael P Fautsch
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-15       Impact factor: 4.799

6.  Epidemiology of Obstructive Sleep Apnea: a Population-based Perspective.

Authors:  Won Lee; Swamy Nagubadi; Meir H Kryger; Babak Mokhlesi
Journal:  Expert Rev Respir Med       Date:  2008-06-01       Impact factor: 3.772

7.  Obstructive sleep apnea in patients undergoing endoscopic surgical repair of cerebrospinal fluid rhinorrhea.

Authors:  Gitanjali M Fleischman; Emily C Ambrose; Rounak B Rawal; Benjamin Y Huang; Charles S Ebert; Kenneth D Rodriguez; Adam M Zanation; Brent A Senior
Journal:  Laryngoscope       Date:  2014-04-10       Impact factor: 3.325

8.  Burden of sleep apnea: rationale, design, and major findings of the Wisconsin Sleep Cohort study.

Authors:  Terry Young; Mari Palta; Jerome Dempsey; Paul E Peppard; F Javier Nieto; K Mae Hla
Journal:  WMJ       Date:  2009-08

Review 9.  Recognition and treatment of sleep-disordered breathing: an important component of chronic disease management.

Authors:  Peter C Farrell; Glenn Richards
Journal:  J Transl Med       Date:  2017-05-25       Impact factor: 5.531

Review 10.  Surgical repair of spontaneous cerebrospinal fluid (CSF) leaks: A systematic review.

Authors:  Brian C Lobo; Maraya M Baumanis; Rick F Nelson
Journal:  Laryngoscope Investig Otolaryngol       Date:  2017-04-07
View more
  2 in total

1.  Impact of Obesity and Obstructive Sleep Apnea in Lateral Skull Base Cerebrospinal Fluid Leak Repair.

Authors:  Kristen L Yancey; Nauman F Manzoor; Patrick D Kelly; Robert J Yawn; Matthew O'Malley; Alejandro Rivas; David S Haynes; Marc L Bennett
Journal:  Laryngoscope       Date:  2019-11-27       Impact factor: 3.325

Review 2.  Sleep, cerebrospinal fluid, and the glymphatic system: A systematic review.

Authors:  Pearlynne L H Chong; Dea Garic; Mark D Shen; Iben Lundgaard; Amy J Schwichtenberg
Journal:  Sleep Med Rev       Date:  2021-11-18       Impact factor: 11.609

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.